Scolaris Content Display Scolaris Content Display

Limpieza de la herida en las úlceras por presión

Appendices

Appendix 1. Search methods for the second review update ‐ 2010

Electronic searches

For this second review update we searched the following electronic databases:

  • Cochrane Wounds Group Specialised Register (Searched 26/3/10)

  • The Cochrane Central Register of Controlled Trials (CENTRAL) ‐ The Cochrane Library 2010 Issue 1

  • Ovid MEDLINE ‐ 2007 to March Week 2 2010

  • Ovid MEDLINE ‐ In‐Process & Other Non‐Indexed Citations (Searched 24/3/10)

  • Ovid EMBASE ‐ 2007 to 2010 Week 9

  • EBSCO CINAHL ‐ 2007 to March 26 2010

The following search strategy was used in The Cochrane Central Register of Controlled Trials (CENTRAL):

#1 MeSH descriptor Sodium Chloride explode all trees
#2 MeSH descriptor Sodium Hypochlorite explode all trees
#3 MeSH descriptor Saline Solution, Hypertonic explode all trees
#4 MeSH descriptor Iodophors explode all trees
#5 MeSH descriptor Chlorhexidine explode all trees
#6 MeSH descriptor Anti‐Infective Agents, Local explode all trees
#7 MeSH descriptor Disinfectants explode all trees
#8 MeSH descriptor Detergents explode all trees
#9 MeSH descriptor Soaps explode all trees
#10 MeSH descriptor Hydrogen Peroxide explode all trees
#11 MeSH descriptor Benzoyl Peroxide explode all trees
#12 MeSH descriptor Gentian Violet explode all trees
#13 MeSH descriptor Water explode all trees
#14 MeSH descriptor Alcohols explode all trees
#15 MeSH descriptor Solutions explode all trees
#16 normal saline or hypochlorit* or iodophor* or povidone or iodine
or chlorhexidine or hibitane or betadine or antiseptic* or disinfectant* or antiseptic* or detergent* or soap* or “hydrogen peroxide” or “benzoyl peroxide” or “gentian violet” or eusol or dakin* or permanganate or water or "alcohol" or alcohols or solution*
#17 MeSH descriptor Irrigation explode all trees
#18 MeSH descriptor Baths explode all trees
#19 MeSH descriptor Hydrotherapy explode all trees
#20 (wound NEXT clean*) or (wound NEXT cleans*)
#21 wash* or scrub* or swab* or shower* or bath* or soak* or irrigat*
or whirlpool
#22 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11
OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21)
#23 MeSH descriptor Pressure Ulcer explode all trees
#24 pressure NEXT (ulcer* or sore*)
#25 decubitus NEXT (ulcer* or sore*)
#26 (bed NEXT sore*) or bedsore*
#27 (#23 OR #24 OR #25 OR #26)
#28 (#22 AND #27)

The search strategies for Ovid MEDLINE, Ovid EMBASE and EBSCO CINAHL can be found in appendices. The Ovid MEDLINE search was combined with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximizing version (2008 revision). The Ovid EMBASE and EBSCO CINAHL searches was combined with the trial filters developed by the Scottish Intercollegiate Guidelines Network. There were no restrictions on the basis of date or language of publication.

Searching other resources

For the original review, we searched the bibliographies of all retrieved and relevant publications, identified through these strategies. Drug companies who supply cleansing solutions, as identified in the British National Formulary (BNF 2003) and experts in the wound care field, namely: council members of the European Pressure Ulcer Advisory Panel, The European Wound Management Association, The National Pressure Ulcer Advisory Panel and the World Union of Wound Healing Societies, were contacted (by ZM) to identify any studies not located through the primary search, or to identify any further researchers involved in pressure ulcer research, whom the authors could contact directly.

Appendix 2. Ovid MEDLINE search strategy

1 exp Sodium Chloride/
2 exp Sodium Hypochlorite/
3 exp Saline Solution, Hypertonic/
4 exp Iodophors/
5 exp Chlorhexidine/
6 exp Anti‐Infective Agents, Local/
7 exp Disinfectants/
8 exp Detergents/
9 exp Soaps/
10 exp Hydrogen Peroxide/
11 exp Benzoyl Peroxide/
12 exp Gentian Violet/
13 exp Water/
14 exp Alcohols/
15 exp Solutions/
16 (normal saline or hypochlorit$ or iodophor$ or povidone or iodine or chlorhexidine or hibitane or betadine or antiseptic$ or disinfectant$ or antiseptic$ or detergent$ or soap$ or hydrogen peroxide or benzoyl peroxide or gentian violet or eusol or dakin$ or permanganate or water or alcohol$1 or solution$).mp.
17 exp Irrigation/
18 exp Baths/
19 exp Hydrotherapy/
20 (wound clean$ or wound cleans$).mp.
21 (wash$ or scrub$ or swab$ or shower$ or bath$ or soak$ or irrigat$ or whirlpool).mp.
22 or/1‐21
23 exp Pressure Ulcer/
24 (pressure adj (ulcer$ or sore$)).mp.
25 (decubitus adj (ulcer$ or sore$)).mp.
26 (bed adj (ulcer$ or sore$)).mp.
27 or/23‐26
28 22 and 27

Appendix 3. Ovid EMBASE search strategy

1 exp Sodium Chloride/
2 exp Sodium Hypochlorite/
3 exp Saline Solution, Hypertonic/
4 exp Iodophors/
5 exp Chlorhexidine/
6 exp Anti‐Infective Agents, Local/
7 exp Disinfectants/
8 exp Detergents/
9 exp Soaps/
10 exp Hydrogen Peroxide/
11 exp Benzoyl Peroxide/
12 exp Gentian Violet/
13 exp Water/
14 exp Alcohols/
15 exp Solutions/
16 (normal saline or hypochlorit$ or iodophor$ or povidone or iodine or chlorhexidine or hibitane or betadine or antiseptic$ or disinfectant$ or antiseptic$ or detergent$ or soap$ or hydrogen peroxide or benzoyl peroxide or gentian violet or eusol or dakin$ or permanganate or water or alcohol$1 or solution$).mp.
17 exp Irrigation/
18 exp Baths/
19 exp Hydrotherapy/
20 (wound clean$ or wound cleans$).mp.
21 (wash$ or scrub$ or swab$ or shower$ or bath$ or soak$ or irrigat$ or whirlpool).mp.
22 or/1‐21
23 exp Pressure Ulcer/
24 (pressure adj (ulcer$ or sore$)).mp.
25 (decubitus adj (ulcer$ or sore$)).mp.
26 (bed adj (ulcer$ or sore$)).mp.
27 or/23‐26
28 22 and 27

Appendix 4. EBSCO CINAHL search strategy

S28 S22 and S27
S27 S23 or S24 or S25 or S26
S26 TI (bed sore* or bedsore* ) or AB (bed sore* or bedsore*)
S25 TI decubitus or AB decubitus
S24 TI (pressure ulcer* or pressure sore*) or AB (pressure ulcer* or pressure sore*)
S23 (MH "Pressure Ulcer")
S22 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20 or S21
S21 TI ( wash* or scrub* or swab* or shower* or bath* or soak* or irrigat* or whirlpool ) or AB ( wash* or scrub* or swab* or shower* or bath* or soak* or irrigat* or whirlpool )
S20 TI ( wound clean* or wound cleans* ) or AB ( wound clean* or wound cleans* )
S19 (MH "Hydrotherapy+")
S18 (MH "Bathing and Baths")
S17 (MH "Irrigation+")
S16 AB ( normal saline or hypochlorit* or iodophor* or povidone or iodine or chlorhexidine or hibitane or betadine or antiseptic* or disinfectant* or antiseptic* or detergent* or soap* or hydrogen peroxide or benzoyl peroxide or gentian violet or eusol or dakin* or permanganate or water or alcohol*1 or solution* )
S15 TI ( normal saline or hypochlorit* or iodophor* or povidone or iodine or chlorhexidine or hibitane or betadine or antiseptic* or disinfectant* or antiseptic* or detergent* or soap* or hydrogen peroxide or benzoyl peroxide or gentian violet or eusol or dakin* or permanganate or water or alcohol*1 or solution* )
S14 (MH "Solutions+")
S13 (MH "Alcohols+")
S12 (MH "Water+")
S11 (MH "Gentian Violet")
S10 (MH "Hydrogen Peroxide")
S9 (MH "Soaps")
S8 (MH "Detergents+")
S7 (MH "Disinfectants")
S6 (MH "Antiinfective Agents, Local+")
S5 (MH "Povidone‐Iodine")
S4 (MH "Chlorhexidine")
S3 (MH "Saline Solution, Hypertonic")
S2 (MH "Sodium Hypochlorite")
S1 (MH "Sodium Chloride+")

Appendix 5. The Cochrane Collaboration tool for assessing risk of bias

1.  Was the allocation sequence randomly generated?

Low risk of bias

The investigators describe a random component in the sequence generation process such as: referring to a random number table; using a computer random number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.

High risk of bias

The investigators describe a non‐random component in the sequence generation process. Usually, the description would involve some systematic, non‐random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.

Unclear

Insufficient information about the sequence generation process to permit judgement of low or high risk of bias.

2.  Was the treatment allocation adequately concealed?

Low risk of bias

Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation: central allocation (including telephone, web‐based and pharmacy‐controlled randomisation); sequentially‐numbered drug containers of identical appearance; sequentially‐numbered, opaque, sealed envelopes.

High risk of bias

Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on: using an open random allocation schedule (e.g. a list of random numbers); assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non opaque or not sequentially numbered); alternation or rotation; date of birth; case record number; any other explicitly unconcealed procedure.

Unclear

Insufficient information to permit judgement of low or high risk of bias. This is usually the case if the method of concealment is not described or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.

3.  Blinding ‐ was knowledge of the allocated interventions adequately prevented during the study?

Low risk of bias

Any one of the following.

  • No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by lack of blinding.

  • Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.

  • Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non‐blinding of others unlikely to introduce bias.

High risk of bias

Any one of the following.

  • No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.

  • Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.

  • Either participants or some key study personnel were not blinded, and the non‐blinding of others likely to introduce bias.

Unclear

Any one of the following.

  • Insufficient information to permit judgement of low or high risk of bias.

  • The study did not address this outcome.

4. Were incomplete outcome data adequately addressed?

Low risk of bias

Any one of the following.

  • No missing outcome data.

  • Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias).

  • Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.

  • For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate.

  • For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size.

  • Missing data have been imputed using appropriate methods.

High risk of bias

Any one of the following.

  • Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups.

  • For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate.

  • For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size.

  • ‘As‐treated’ analysis done with substantial departure of the intervention received from that assigned at randomisation.

  • Potentially inappropriate application of simple imputation.

Unclear

Any one of the following.

  • Insufficient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated, no reasons for missing data provided).

  • The study did not address this outcome.

5. Are reports of the study free of suggestion of selective outcome reporting?

Low risk of bias

Any of the following.

  • The study protocol is available and all of the study’s pre‐specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre‐specified way.

  • The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre‐specified (convincing text of this nature may be uncommon)

High risk of bias

Any one of the following.

  • Not all of the study’s pre‐specified primary outcomes have been reported.

  • One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre‐specified.

  • One or more reported primary outcomes were not pre‐specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect).

  • One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta‐analysis.

  • The study report fails to include results for a key outcome that would be expected to have been reported for such a study.

Unclear

Insufficient information to permit judgement of low or high risk of bias. It is likely that the majority of studies will fall into this category.

6. Other sources of potential bias

Low risk of bias

The study appears to be free of other sources of bias.

High risk of bias

There is at least one important risk of bias. For example, the study:

  • had a potential source of bias related to the specific study design used; or

  • had extreme baseline imbalance; or

  • has been claimed to have been fraudulent; or

  • had some other problem.

Unclear

There may be a risk of bias, but there is either:

  • insufficient information to assess whether an important risk of bias exists; or

  • insufficient rationale or evidence that an identified problem will introduce bias.

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
Figuras y tablas -
Figure 1

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.

Comparison 1 Different cleansing techniques, Outcome 1 Pulsatile Lavage versus sham.
Figuras y tablas -
Analysis 1.1

Comparison 1 Different cleansing techniques, Outcome 1 Pulsatile Lavage versus sham.

Comparison 2 Different cleansing solutions, Outcome 1 Saline versus tap water.
Figuras y tablas -
Analysis 2.1

Comparison 2 Different cleansing solutions, Outcome 1 Saline versus tap water.

Table 1. Bellingeri 2004 Table of results

Intervention

PSST Baseline

PSST Day 7

PSST Day 14

Total % Change

Isotonic saline solution (control)

mean 31.6 (SD 10.3, min 15.0, max 52.0)

28.9 (SD 10.5, min 12.0, max 52.0).

25.3 (SD 12.2, min 10.0, max 50.0).

‐20.5 (SD 24.1, min ‐65.8, max 22.7).

Saline spray, Aloe vera, silver chloride and decyl glucoside (Vulnopur) (intervention)

mean 31.3 (SD 11.5, min 13.0 max 56.0)

27.1 (SD 11.1, min 13.0, max 54.0).

21.6 (SD 11.6, min 10.0, max 51,0).

‐27.8 (SD 31.3, min ‐69.8, max 123.5).

Figuras y tablas -
Table 1. Bellingeri 2004 Table of results
Comparison 1. Different cleansing techniques

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Pulsatile Lavage versus sham Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.1 Changes in Volume

1

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

Figuras y tablas -
Comparison 1. Different cleansing techniques
Comparison 2. Different cleansing solutions

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Saline versus tap water Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.1 Healed wound within 6 weeks

1

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Figuras y tablas -
Comparison 2. Different cleansing solutions